Clinical Trial Update: Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 2]

View source ↗

Summary

A randomized, double-blind, Phase 2 dose-range-finding study evaluated linaclotide for irritable bowel syndrome with constipation; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linzess (linaclotide)

Snippet

Sponsor: Ironwood Pharmaceuticals, Inc. | Conditions: Irritable Bowel Syndrome With Constipation | Phase 2 | Status: COMPLETED | Results posted: 2013-01-30